{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:40:27Z","timestamp":1785368427796,"version":"3.55.0"},"reference-count":54,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Hemopexin (Hpx) is considered a factor in the pathogenesis of idiopathic nephrotic syndrome (INS). The aim of the study was to evaluate the serum and urine values of Hpx (sHpx and uHpx) in children with INS, analyze the role of Hpx, and assess its usefulness as a marker of the disease course. 51 children with INS and 18 age-matched controls were examined. Patients were divided into subgroups depending on the number of relapses (group IA\u2014the first episode of INS, group IB\u2014with relapses) and according to method of treatment (group IIA treated with gluco-corticosteroids (GCS), group IIB treated with GCS and other immunosuppressants). Hpx concentrations were determined by enzyme-linked immunosorbent assay (ELISA). sHpx and uHpx values in relapse were elevated in the whole INS group versus controls (p &lt; 0.000). In remission their levels decreased, but still remained higher than in the control group (p &lt; 0.000). In group IB uHpx levels were increased during remission as compared to group IA (p &lt; 0.006). No significant impact of immuno-suppressants on sHpx was observed, but uHpx excretion in group IIA was higher in relapse (p &lt; 0.026) and lower in remission (p &lt; 0.0017) as compared to group IIB. The results suggest the role of Hpx in the pathogenesis of INS. Hpx may be a useful indicator for continuation of treatment, but it requires confirmation by further controlled studies.<\/jats:p>","DOI":"10.3390\/jcm10143160","type":"journal-article","created":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T21:16:48Z","timestamp":1626643008000},"page":"3160","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Involvement of Hemopexin in the Pathogenesis of Proteinuria in Children with Idiopathic Nephrotic Syndrome"],"prefix":"10.3390","volume":"10","author":[{"given":"Agnieszka","family":"Pukaj\u0142o-Marczyk","sequence":"first","affiliation":[{"name":"Department of Pediatric Nephrology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Zwoli\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/s41431-020-0642-8","article-title":"Genetic aspects of congenital nephrotic syndrome: A consensus statement from the ERKNet-ESPN inherited glomerulopathy working group","volume":"28","author":"Ozaltin","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ajpath.2020.04.001","article-title":"Podocytes: The Role of Lysosomes in the Development of Nephrotic Syndrome","volume":"190","author":"Giliberti","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00467-016-3502-6","article-title":"IgA nephropathy with presentation of nephrotic syndrome at onset in children","volume":"32","author":"Shima","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Peruzzi, L., and Coppo, R. (2020). IgA vasculitis nephritis in children and adults: One or different entities?. Pediatr. Nephrol., 20.","DOI":"10.1007\/s00467-020-04818-7"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/2175-8239-jbn-2018-0097","article-title":"Pediatric lupus nephritis","volume":"41","author":"Pinheiro","year":"2019","journal-title":"Braz. J. Nephrol."},{"key":"ref_6","unstructured":"(2021, May 30). Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/713276\/."},{"key":"ref_7","unstructured":"(2012, May 30). KDIGO Clinical Practice Guideline for Glomerulonephritis. Available online: https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO-2012-GN-Guideline-English.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","article-title":"Treatment of steroid-sensitive nephrotic syndrome: New guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00467-015-3136-0","article-title":"A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome","volume":"30","author":"Oliveira","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12519-020-00400-1","article-title":"Immunopathogenesis of idiopathic nephrotic syndrome in children: Two sides of the coin","volume":"17","author":"Chen","year":"2021","journal-title":"World J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTION","volume":"304","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s004670050276","article-title":"Effect of interleukin-8 on glomerular sulfated compounds and albuminuria","volume":"11","author":"Garin","year":"1997","journal-title":"Pediatr. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1203\/PDR.0b013e318186ddb2","article-title":"Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria","volume":"64","author":"Souto","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of Interleukin-13 Induces Minimal-Change\u2013Like Nephropathy in Rats","volume":"18","author":"Lai","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1097\/01.ASN.0000136312.46464.33","article-title":"Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome","volume":"15","author":"Reiser","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00467-010-1676-x","article-title":"Minimal change disease: A \u201ctwo-hit\u201d podocyte immune disorder?","volume":"26","author":"Shimada","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00467-014-2874-8","article-title":"Minimal change disease: A dysregulation of the podocyte CD80\u2013CTLA-4 axis?","volume":"29","author":"Wasserfall","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneph.2012.289-c1","article-title":"Effect of rituximab in MCNS: A role for IL-13 suppression?","volume":"9","author":"Kim","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","article-title":"The glomerular permeability factors in idiopathic nephrotic syndrome","volume":"31","author":"Davin","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.2012030302","article-title":"PodoNet and FSGS CT Study Consortia. Circulating suPAR in Two Cohorts of Primary FSGS","volume":"23","author":"Wei","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2215\/CJN.02370314","article-title":"Relationship between Serum Soluble Urokinase Plasminogen Activator Receptor Level and Steroid Responsiveness in FSGS","volume":"9","author":"Li","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ckj\/sfv090","article-title":"A circulating permeability factor in focal segmental glomerulosclerosis: The hunt continues","volume":"8","author":"Wada","year":"2015","journal-title":"Clin. Kidney J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00467-013-2679-1","article-title":"CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: Diagnostic and pathogenic significance","volume":"29","author":"Wei","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"ref_24","first-page":"536","article-title":"Hemopexin","volume":"163","year":"1998","journal-title":"Methods Enzymol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01534930","article-title":"Hemopexin is localized to human chromosome 11","volume":"13","author":"Naylor","year":"1987","journal-title":"Somat. Cell Mol. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02138368","article-title":"Structure of the human hemopexin gene and evidence for intron-mediated evolution","volume":"27","author":"Altruda","year":"1988","journal-title":"J. Mol. Evol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1073\/pnas.82.1.73","article-title":"Complete aminoacid sequence of human hemopexin, the heme-binding protein of serum","volume":"82","author":"Takahasi","year":"1985","journal-title":"Proc. Natl. Acid. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ferreira, G.C., Moura, J.J.G., and Franco, R. (1999). Role of Redox-Reactive Metals in the Regulation of Metallothionein and Hemeoxygenase Genes by Heme and Hemopexin. Iron Metabolism, Wiley-VCH.","DOI":"10.1002\/9783527613700"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0009-8981(01)00586-1","article-title":"Hemopexin: A review of biological aspects and the role in laboratory medicine","volume":"312","author":"Delanghe","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0009-8981(90)90178-U","article-title":"Urinary proteins and red blood cell membrane negative charges in diabetes mellitus","volume":"190","author":"Bernard","year":"1990","journal-title":"Clin. Chim. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.jprot.2012.04.047","article-title":"Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: Role of glucose-induced ROS","volume":"75","author":"Chen","year":"2012","journal-title":"J. Proteom."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","article-title":"Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs","volume":"66","author":"Maes","year":"1997","journal-title":"Psychiatry Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0009-8981(71)90425-6","article-title":"Serum haemopexin levels in patients with malignant melanoma","volume":"31","author":"Manuel","year":"1971","journal-title":"Clin. Chim. Acta"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.1320180212","article-title":"Serum myoglobin in Duchenne muscular dystrophy carrier detection: A comparison with creatine kinase and hemopexin using logistic discrimination","volume":"18","author":"Percy","year":"1984","journal-title":"Am. J. Med. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"International Study of Kidney Disease in Children (1981). Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int., 20, 765\u2013771.","DOI":"10.1038\/ki.1981.209"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New Equations to Estimate GFR in Children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_37","first-page":"1218","article-title":"Enhanced glomerular permeability andminimal change disease like alterations of the rat kidney indced by a vasoactive human plasma factor","volume":"47","author":"Cheung","year":"1995","journal-title":"Kidney Int."},{"key":"ref_38","first-page":"562","article-title":"Induction of experimental proteinuria in vivo following infusion of a human stain factor associated with minimal change disease","volume":"52","author":"Cheung","year":"1997","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1159\/000189457","article-title":"Minimal change-like glomerular alterations induced by a human plasma factor","volume":"74","author":"Cheung","year":"1996","journal-title":"Nephron"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1681\/ASN.V1081700","article-title":"Is 100KF an Isoform of Hemopexin? Immunochemical Characterization of the Vasoactive Plasma Factor 100KF","volume":"10","author":"Cheung","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1523-1755.2005.00438.x","article-title":"Protease activity of plasma hemopexin","volume":"68","author":"Bakker","year":"2005","journal-title":"Kidney Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1681\/ASN.2007080940","article-title":"Hemopexin Induces Nephrin-Dependent Reorganization of the Actin Cytoskeleton in Podocytes","volume":"19","author":"Lennon","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00467-005-1936-3","article-title":"Altered activity of plasma hemopexin in patients with minimal change disease in relapse","volume":"20","author":"Bakker","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"ref_44","unstructured":"Thomas, L. (1998). Haptoglobin\/Hemopexin. Clinical Laboratory Diagnostics, TH-Books."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/clinchem\/41.4.605","article-title":"Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months","volume":"41","author":"Kanakoudi","year":"1995","journal-title":"Clin. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.0954-6820.1972.tb04794.x","article-title":"The concentration of 21 serum proteins in normal children and adults","volume":"192","author":"Weeke","year":"2009","journal-title":"Acta Med. Scand."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/104454902753759717","article-title":"Hemopexin: Structure, Function, and Regulation","volume":"21","author":"Tolosano","year":"2002","journal-title":"DNA Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ndt\/gfaa279","article-title":"Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults","volume":"36","author":"Oniszczuk","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_49","first-page":"632","article-title":"Predictive Value of Serum Interleukins in Children with Idiopathic Nephrotic Syndrome","volume":"19","author":"Nickavar","year":"2020","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1523-1755.2003.00907.x","article-title":"Production of hemopexin by TNF-\u03b1 stimulated human mesangial cells","volume":"63","author":"Kapojos","year":"2003","journal-title":"Kidney Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1432-2277.2010.01055.x","article-title":"High plasma hemopexin activity is an independent risk factor for late graft failure in renal transplant recipients","volume":"23","author":"Krikken","year":"2010","journal-title":"Transpl. Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5114\/fmpcr\/42427","article-title":"The role of IL-13 in the pathogenesis of idiopathic nephrotic syndrome (INS) in children","volume":"2","year":"2016","journal-title":"Fam. Med. Prim. Care Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1189\/jlb.1208742","article-title":"Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages","volume":"86","author":"Liang","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/654929","article-title":"Synergistic Inflammation Is Induced by Blood Degradation Products with Microbial Toll-Like Receptor Agonists and Is Blocked by Hemopexin","volume":"202","author":"Lin","year":"2010","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/14\/3160\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:31:15Z","timestamp":1760164275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/14\/3160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,17]]},"references-count":54,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["jcm10143160"],"URL":"https:\/\/doi.org\/10.3390\/jcm10143160","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,17]]}}}